myprostatecancertreatment.org Report : Visit Site

Technical data of the myprostatecancertreatment.org

Geo IP provides you such as latitude, longitude and ISP (Internet Service Provider) etc. informations. Our GeoIP service found where is host myprostatecancertreatment.org. Currently, hosted in United States and its service provider is UltraDNS Corp .

the related websites

photopendant.co.uk myprostatecancercoach.org roadheaders.co.uk wplgroup.com nottinghamcomiccon.co.uk evaluategroup.com urotoday.com genomichealth.com 

HTTP Header Analysis

HTTP Header information is a part of HTTP protocol that a user's browser sends to called Microsoft-IIS/8.5 containing the details of what the browser wants and will accept back from the web server.

DNS

HtmlToText

home treatment options prostate cancer treatment options your prostate cancer diagnosis treatment facts at a glance active surveillance prostate surgery radiation therapy other treatment options about oncotype dx oncotype dx test for prostate cancer role of genomics in treatment gps score insurance coverage faq is oncotype dx for you? take the eligibility quiz questions to ask your doctor friends & family resources helpful resources oncotype dx guides video center glossary more online resources my prostate cancer treatment 1.855.6.prostate treatment options prostate cancer treatment options your prostate cancer diagnosis treatment facts at a glance active surveillance prostate surgery radiation therapy other treatment options about oncotype dx oncotype dx test for prostate cancer role of genomics in treatment gps score insurance coverage faq is oncotype dx for you? take the eligibility quiz questions to ask your doctor friends & family resources helpful resources oncotype dx guides video center glossary more online resources is your prostate cancer low-risk? how can you be sure? personalize your treatment with oncotype dx. see jim's story jim, prostate cancer survivor and oncotype dx patient active surveillance or immediate treatment? over 50% of newly diagnosed men have low risk prostate cancer that is unlikely to spread 1 yet a majority of them receive immediate aggressive treatment, which may lead to impotence and incontinence download questions to ask your doctor is oncotype dx right for you? results from the oncotype dx test changed treatment recommendations for 1 in 4 patients 2 take the quiz support your loved one in his journey get the doctor discussion guide find resources to help support your loved one hear how deb helped her husband dan decide his treatment plan 1 cooperberg. 2010. jco 2 badani et al. 2014. suo contact us 1.855.6.prostate (1.855.677.6782) resources myprostatecancercoach.org oncotypeiq.com legal terms of use privacy policy notice of hipaa practices © 2013-2018 genomic health prostate cancer treatment options you have options. treatment is not “one size fits all.” your prostate cancer diagnosis treatment facts at a glance is active surveillance right for you? removing your prostate gland using energy to kill prostate cancer cells additional prostate cancer treatment choices about oncotype dx get help choosing the right treatment with the oncotype dx test personalizing your prostate cancer treatment through genomics gps score insurance coverage faq is oncotype dx for you? take the eligibility quiz talking to your doctor about prostate cancer friends & family resources helpful resources oncotype dx guides video center glossary more online resources prostate cancer treatment options you have options. treatment is not “one size fits all.” your prostate cancer diagnosis treatment facts at a glance is active surveillance right for you? removing your prostate gland using energy to kill prostate cancer cells additional prostate cancer treatment choices about oncotype dx get help choosing the right treatment with the oncotype dx test personalizing your prostate cancer treatment through genomics gps score insurance coverage faq is oncotype dx for you? take the eligibility quiz talking to your doctor about prostate cancer friends & family resources helpful resources oncotype dx guides video center glossary more online resources oncotype dx legal information the information presented on this site is intended to provide patients with newly diagnosed prostate cancer, as well as their friends and family, an opportunity to learn how the information provided by the oncotype dx genomic prostate score can be used, along with other clinical measures, to help patients and their doctors make treatment decisions. patients should consult their doctor to determine the best treatment decision for their individual disease. national comprehensive cancer network (nccn) and nccn are registered trademarks of nccn. nccn does not endorse any product or therapy. copyright © 2013-2018 genomic health, inc. all rights reserved. genomic health, oncotype, and oncotype dx are trademarks, and genomic prostate score is a pending registered trademark of genomic health inc. myprostatecancertreatment.org is sponsored by genomic health, inc., a clinical laboratory in redwood city, california that developed and offers the oncotype dx prostate cancer assay. genomic health is responsible for the content of myprostatecancertreatment.org.

URL analysis for myprostatecancertreatment.org

http://www.myprostatecancertreatment.org/prostate-cancer-family-resources/prostate-cancer-family-resources.aspx
http://www.myprostatecancertreatment.org/about-oncotype-dx/insurance-information
http://www.myprostatecancertreatment.org/oncotype-dx-eligibility-quiz
http://www.myprostatecancertreatment.org/prostate-cancer-treatment-options/prostate-cancer-diagnosis
http://www.myprostatecancertreatment.org/helpful-resources
http://www.myprostatecancertreatment.org/about-oncotype-dx/oncotype-dx-for-prostate-cancer.aspx
http://www.myprostatecancertreatment.org/about-oncotype-dx/oncotype-dx-genomic-prostate-score
http://www.myprostatecancertreatment.org/~/media/mpct/oncotypedxprostatecancer_doctor_discussion_guide.ashx
http://www.myprostatecancertreatment.org/helpful-resources/oncotype-dx-resources.aspx
http://www.myprostatecancertreatment.org/global/terms-of-use
http://www.myprostatecancertreatment.org/prostate-cancer-treatment-options/prostate-cancer-treatment-options
http://www.myprostatecancertreatment.org/about-oncotype-dx
http://www.myprostatecancertreatment.org/prostate-cancer-treatment-options
http://www.myprostatecancertreatment.org/prostate-cancer-treatment-options/other-treatment-options
http://www.myprostatecancertreatment.org/prostate-cancer-treatment-options/prostate-surgery

Whois Information

Whois is a protocol that is access to registering information. You can reach when the website was registered, when it will be expire, what is contact details of the site with the following informations. In a nutshell, it includes these informations;

Domain Name: MYPROSTATECANCERTREATMENT.ORG
Registry Domain ID: D162018787-LROR
Registrar WHOIS Server: whois.register.com
Registrar URL: http://www.register.com
Updated Date: 2018-03-29T14:32:25Z
Creation Date: 2011-04-12T21:49:34Z
Registry Expiry Date: 2023-04-12T21:49:34Z
Registrar Registration Expiration Date:
Registrar: Register.com, Inc.
Registrar IANA ID: 9
Registrar Abuse Contact Email: [email protected]
Registrar Abuse Contact Phone: +1.8003337680
Reseller:
Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited
Registrant Organization: Genomic Health, Inc
Registrant State/Province: CA
Registrant Country: US
Name Server: UDNS1.ULTRADNS.NET
Name Server: UDNS2.ULTRADNS.NET
DNSSEC: unsigned
URL of the ICANN Whois Inaccuracy Complaint Form: https://www.icann.org/wicf/
>>> Last update of WHOIS database: 2018-06-22T19:25:51Z <<<

For more information on Whois status codes, please visit https://icann.org/epp

Access to Public Interest Registry WHOIS information is provided to assist persons in determining the contents of a domain name registration record in the Public Interest Registry registry database. The data in this record is provided by Public Interest Registry for informational purposes only, and Public Interest Registry does not guarantee its accuracy. This service is intended only for query-based access. You agree that you will use this data only for lawful purposes and that, under no circumstances will you use this data to (a) allow, enable, or otherwise support the transmission by e-mail, telephone, or facsimile of mass unsolicited, commercial advertising or solicitations to entities other than the data recipient's own existing customers; or (b) enable high volume, automated, electronic processes that send queries or data to the systems of Registry Operator, a Registrar, or Afilias except as reasonably necessary to register domain names or modify existing registrations. All rights reserved. Public Interest Registry reserves the right to modify these terms at any time. By submitting this query, you agree to abide by this policy.

Please query the RDDS service of the Registrar of Record identified in this output for information on how to contact the Registrant, Admin, or Tech contact of the queried domain name.

  REFERRER http://www.pir.org/

  REGISTRAR Public Interest Registry

SERVERS

  SERVER org.whois-servers.net

  ARGS myprostatecancertreatment.org

  PORT 43

  TYPE domain

DOMAIN

  NAME myprostatecancertreatment.org

  HANDLE D162018787-LROR

  CREATED 2011-12-04

STATUS
clientTransferProhibited https://icann.org/epp#clientTransferProhibited

NSERVER

  UDNS1.ULTRADNS.NET 204.69.234.1

  UDNS2.ULTRADNS.NET 204.74.101.1

OWNER

  ORGANIZATION Genomic Health, Inc

ADDRESS

  STATE CA

  COUNTRY US

  REGISTERED yes

Mistakes

The following list shows you to spelling mistakes possible of the internet users for the website searched .